Clinical Trial Update: Benralizumab Pregnancy Exposure Study

View source ↗

Summary

A pregnancy exposure study of benralizumab for asthma sponsored by AstraZeneca has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• FASENRA (BENRALIZUMAB)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Status: TERMINATED